Business Name: C3
Business Segment: MBA Fakhro / Greenfield Capital / Genomics
Year Founded: 2018
Fund Name: MBA Fakhro – Greenfield Capital Two
Ownership: MBA Fakhro – Greenfield Capital Two owns 100% of C3
Business Overview: C3 is a Silicon Valley based genomics company that aims to find a cure for cancer by working to edit faulty genes using CRISPR and other technologies, and to help people get treated from cancer by developing innovative drugs that allow for more effective cancer treatments. The company name is an abbreviation of Cure Cancer Company.